UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Axxcess Wealth Management LLC

Axxcess Wealth Management LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 29,333 shares of the healthcare conglomerate’s stock after purchasing an additional 2,573 shares during the quarter. Axxcess Wealth Management LLC’s holdings in UnitedHealth Group were worth $15,443,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Power Wealth Management LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $203,000. U.S. Capital Wealth Advisors LLC lifted its holdings in UnitedHealth Group by 27.2% in the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 14,595 shares of the healthcare conglomerate’s stock worth $7,684,000 after buying an additional 3,120 shares in the last quarter. Horan Capital Advisors LLC. increased its position in shares of UnitedHealth Group by 5.2% during the fourth quarter. Horan Capital Advisors LLC. now owns 1,145 shares of the healthcare conglomerate’s stock worth $603,000 after acquiring an additional 57 shares during the last quarter. Bordeaux Wealth Advisors LLC boosted its holdings in UnitedHealth Group by 19.5% in the fourth quarter. Bordeaux Wealth Advisors LLC now owns 1,795 shares of the healthcare conglomerate’s stock valued at $945,000 after purchasing an additional 293 shares during the last quarter. Finally, 9258 Wealth Management LLC lifted its holdings in UnitedHealth Group by 7.3% during the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock worth $2,250,000 after buying an additional 290 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on UNH shares. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Barclays raised their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Piper Sandler raised their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Finally, Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Four analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

NYSE:UNH traded down $0.52 during mid-day trading on Friday, reaching $492.45. The stock had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock has a market capitalization of $453.09 billion, a PE ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The stock has a 50-day simple moving average of $482.32 and a two-hundred day simple moving average of $512.76.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same quarter last year, the firm posted $6.26 EPS. The company’s quarterly revenue was up 8.6% on a year-over-year basis. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.